The findings, published in JAMA Cardiology, confirm that dapagliflozin is a safe, effective treatment option for patients with heart failure with reduced ejection fraction.

A group of 11 societies issued a practice advisory recently to help physicians better select contrast agents and manage adverse events.

The study's authors tracked the health of more than 134,000 individuals from 21 countries for nearly a decade. 

The proportion of patients treated for invasive carcinoma or an advanced stage of the disease have both leapt in recent years, experts wrote in Clinical Imaging. 

The American Rescue Plan, the $1.9 trillion Covid-19 relief law that provided stimulus checks to most Americans, included several healthcare changes that will reduce costs for many Americans. The Biden administration is now preparing to spend $50 million in advertising to promote those healthcare changes,

A new study reveals Blacks, Latinos, and Native Americans are “severely” underrepresented in the healthcare workforce, an issue that could exacerbate disease disparities.

The Federal Trade Commission is suing Illumina, a gene sequencing firm, in an effort to stop its proposed $7.1 billion acquisition of life sciences firm Grail. 

The ratings agency first issued its downgrade in July, citing the risk of prolonged business impact from COVID-19 and uncertainty around radiology's future. 

The FDA has given the all-clear to AI software that measures nodules in the lungs, a tedious but important task for radiologists monitoring changes in these growths over time.

Research Endpoints will manage the growing demand for the Scottsdale, Arizona-based firm's imaging research and biomarker business, according to an announcement made Wednesday.